Project 1
项目1
基本信息
- 批准号:8376300
- 负责人:
- 金额:$ 19.44万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-08-11 至 2015-04-30
- 项目状态:已结题
- 来源:
- 关键词:AdolescentAdverse effectsAffectAgeAmyotrophic Lateral SclerosisAnimalsAntibodiesAreaAxonBehaviorBehavioralBiochemicalBiologicalBiological AssayBiological MarkersBiological ModelsCell Culture SystemCell DeathCell ExtractsCell SurvivalCellsCellular MorphologyCessation of lifeClinicalCoculture TechniquesCohort EffectCollaborationsCrystallinsDetectionDevelopmentDiagnostic ProcedureDiseaseDisease PathwayDisease modelDrug Delivery SystemsElectrophysiology (science)EpitopesEvaluationEventExhibitsFluorescence MicroscopyFree Radical FormationFutureGenesGoalsGrantGreen Fluorescent ProteinsHumanIn VitroInvestigationKnowledgeLaboratoriesLengthLinkLocationMeasurementMeasuresMediatingMembrane PotentialsMetalsMicrotubulesMitochondriaModelingMolecularMolecular ConformationMotorMotor NeuronsMouse StrainsMovementMusNerve DegenerationNeurogliaNeuronsOrganellesPathway interactionsPatientsPatternPeptidesPharmaceutical PreparationsPhysiologicalPlayPreparationProcessPropertyProteinsPublishingReporterResearchRoleSignal PathwaySpinal CordStagingStaining methodStainsStem cellsSynapsesSynchrotronsSystemTechniquesTestingTetanus Helper PeptideTherapeuticTimeTissuesToxic effectTransfectionTransgenesTransgenic OrganismsUbiquitinViral VectorWorkbasecell typecytochrome cdesignhuman diseasehuman embryonic stem cellimprovedin vivoinhibitor/antagonistmitochondrial membranemotor neuron degenerationmouse modelmulticatalytic endopeptidase complexmutantneuron lossoverexpressionoxidationpreventprogramspromoterprotein aggregateprotein aggregationrelating to nervous systemresearch studysuperoxide dismutase 1synaptogenesisuptakevector
项目摘要
Aggregation and fibrillation of SODl have been implicated in disease mechanisms of Amyotrophic Lateral
Sclerosis (ALS), and it is a major new goal of this Program Project renewal to develop better biological assays to
study the toxicity of these multimeric forms of SODl in systems that will be more relevant to the disease in
humans. In Project 2 we further develop and use a human cell culture system that closely models important cell
biological aspects of motor neuron degeneration¿our recently developed human embryonic stem cell-derived
motor neuron (HESC-MN) system. The cells have distinct advantages over other model systems as they represent
the major cell type that degenerates in ALS and they are fully human. The cells express identifying neuronal
markers, exhibit electrophysiological function typical for mature motor neurons, and can be co-cultured with
other neuronal and non-neuronal cells. Transfection of these cells to express ALS-SODl proteins causes
deleterious effeds on cell survival and morphology. Importantly for this project, we have recently shown that
exogenously added ALS-SODl protein multimers are taken up quite well. We will utilize these cells to study the
toxicity of SODl protein multimers and aggregates at different stages of their formation and relate it to the
progression of motor neuron degeneration. This research plan outlines a highly collaborative, step-by-step
approach to evaluate spontaneous and induced mutant and WT SODl aggregate formation in motor neurons,
followed by an investigation of the consequences of SODl aggregates on neurodegenerative mechanisms and,
finally, by using pharmacological inhibitors of SODl aggregation to investigate whether reduced SODl
aggregation can prevent motor neuron death.
SODl的聚集和原纤化已经涉及肌萎缩侧索硬化的疾病机制。
硬化症(ALS),这是一个主要的新目标,该计划项目更新,以开发更好的生物测定,
研究这些多聚体形式的SOD 1在系统中的毒性,这些系统将与疾病更相关,
人类在项目2中,我们进一步开发和使用人类细胞培养系统,
运动神经元变性的生物学方面?我们最近开发的人类胚胎干细胞衍生的
运动神经元(HESC-MN)系统。这些单元与其他模型系统相比具有明显的优势,
ALS中退化的主要细胞类型,它们是完全人类的。细胞表达识别神经元
标记物,表现出成熟运动神经元典型的电生理功能,并且可以与
其他神经元和非神经元细胞。转染这些细胞以表达ALS-SOD 1蛋白,导致
对细胞存活和形态的有害作用。对于这个项目来说,重要的是,我们最近已经证明,
外源添加的ALS-SOD 1蛋白多聚体被很好地吸收。我们将利用这些细胞来研究
在其形成的不同阶段,SOD 1蛋白多聚体和聚集体的毒性,并将其与细胞毒性相关。
运动神经元变性的进展。该研究计划概述了一个高度协作,逐步
评估运动神经元中自发和诱导的突变体和WT SOD 1聚集体形成的方法,
接着研究SOD 1聚集体对神经变性机制的影响,
最后,通过使用SOD 1聚集的药理学抑制剂来研究是否减少了SOD 1
聚集可以防止运动神经元死亡。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOAN Selverstone VALENTINE其他文献
JOAN Selverstone VALENTINE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOAN Selverstone VALENTINE', 18)}}的其他基金
Molecular Mechanisms of SOD1-linked ALS (P01)
SOD1 相关 ALS 的分子机制 (P01)
- 批准号:
8644318 - 财政年份:2005
- 资助金额:
$ 19.44万 - 项目类别:
Molecular Mechanisms of SOD1-linked ALS (P01)
SOD1 相关 ALS 的分子机制 (P01)
- 批准号:
7110223 - 财政年份:2005
- 资助金额:
$ 19.44万 - 项目类别:
Folding Defects and the Role of Copper in SOD1-FALS
折叠缺陷和铜在 SOD1-FALS 中的作用
- 批准号:
6902780 - 财政年份:2005
- 资助金额:
$ 19.44万 - 项目类别:
Molecular Mechanisms of SOD1-linked ALS (P01)
SOD1 相关 ALS 的分子机制 (P01)
- 批准号:
8249456 - 财政年份:2005
- 资助金额:
$ 19.44万 - 项目类别:
Molecular Mechanisms of SOD1-linked ALS (P01)
SOD1 相关 ALS 的分子机制 (P01)
- 批准号:
8452698 - 财政年份:2005
- 资助金额:
$ 19.44万 - 项目类别:
相似海外基金
Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
- 批准号:
10591918 - 财政年份:2023
- 资助金额:
$ 19.44万 - 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
- 批准号:
23K15383 - 财政年份:2023
- 资助金额:
$ 19.44万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
- 批准号:
23H03556 - 财政年份:2023
- 资助金额:
$ 19.44万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
- 批准号:
23K17212 - 财政年份:2023
- 资助金额:
$ 19.44万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
- 批准号:
22H03519 - 财政年份:2022
- 资助金额:
$ 19.44万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
- 批准号:
563657-2021 - 财政年份:2022
- 资助金额:
$ 19.44万 - 项目类别:
Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10521849 - 财政年份:2022
- 资助金额:
$ 19.44万 - 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10671022 - 财政年份:2022
- 资助金额:
$ 19.44万 - 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
- 批准号:
10670918 - 财政年份:2022
- 资助金额:
$ 19.44万 - 项目类别:
Downsides of downhill: The adverse effects of head vibration associated with downhill mountain biking on visuomotor and cognitive function
速降的缺点:与速降山地自行车相关的头部振动对视觉运动和认知功能的不利影响
- 批准号:
2706416 - 财政年份:2022
- 资助金额:
$ 19.44万 - 项目类别:
Studentship